Imatinib (Resimat) is a protein-tyrosine kinase inhibitor, prescribed for treating certain type of cancers such as chronic myelogenous leukemia (cancer of the white blood cells, acute lymphoblastic leukemia(cancer of the white blood cells), gastrointestinal stromal tumors (tumors of the gastrointestinal tract and other cancers. It prevents the growth of cancer cells.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Resimat - Resonance Laboratories Pvt. Ltd.
Resimat Tablet
Generic : Imatinib
₹
301
10 Tablets
Substitute/Alternative Medication to Resimat
Celonib (400 mg) | Imalak | Lupitib | Lupitib | Mesylonib | Mesylonib (100mg) | Mesylonib (400 mg) | Mesylonib (400mg) | Mitinab | Mitinab (100mg)
When is Resimat prescribed?
It is prescribed for -
